Formulation and Process Optimization of Rauvolfia serpentina Nanosuspension by HPMC and In Vitro Evaluation of ACE Inhibitory Potential
Source abstract
Abstract
Angiotensin converting enzyme (ACE) overactivation is one of the primary causes of hypertension, which leads to cardiovascular disorders all over the world. In the scientific world, nanosuspension is a novel area of study that could offer an alternative treatment for active pharmaceuticals that are not well soluble in water. Since active compounds’ bioavailability is reduced by their poor solubility, there are eventually fewer applications. Drug solubility, dissolving rate, and bioavailability are improved by nanosuspension, which shrinks medication particle size into the nanoscale range and boosts the surface area to volume ratio of the drug. There is a need to prepare Rauvolfia serpentina’s nanosuspension in order to get around some of the major challenges that it faces because of its poor solubility and wide range of biological activities. Using the antisolvent precipitation approach, a nanosuspension of Rauvolfia serpentina was created with hydroxy propyl methyl cellulose (HPMC). Rouvolfia serpentina nanosuspensions were prepared using a design of expert (DOE) approach, which allowed for the evaluation of key process parameters. To get an optimal sample, the effects of stabilizer concentration and anti-solvent volume on particle size, zeta potential, and PdI using CCD-RSM were investigated. Using the substrate Hippuryl-histidyl-leucine, the in vitro ACE inhibitory potential was assessed. On human erythrocytes, the safety of nanosuspension was evaluated in vitro. The ideal value of independent variables was discovered to be 0.25% w/v in order to achieve the desired response. Using scanning electron microscopy, the morphology of optimized nanosuspension was discovered to be rod-shaped (SEM). Compared to nanoformulation, crude extract had higher ACE inhibitory potential (83.11%). Human erythrocytes were found to be unaffected by nano-sized particles.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Analytical Methods in Pharmaceuticals · Pharmacological Effects of Natural Compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Natural Products Lab, Department of Chemistry, University of Agriculture, Faisalabad 38000, Pakistan
Department of Mechanical Engineering, Sejong University, Seoul 05006, Republic of Korea
Department of Mechanical Engineering, Gachon University, Seongnam-si 13120, Republic of Korea
Funding
Higher Education Commission (HEC) of Pakistan
References (29)
Show source-provided references
1. Amadori compounds as potent inhibitors of angiotensin-converting enzyme (ACE) and their effects on anti-ACE activity of bell peppers10.1016/j.jff.2016.10.017 ↗
2. Purification, characterization, synthesis, in vitro ACE inhibition and in vivo antihypertensive activity of bioactive peptides derived from oil palm kernel glutelin-2 hydrolysates10.1016/j.jff.2016.11.021 ↗
3. Effect of germination on antioxidant and ACE inhibitory activities of legumes10.1016/j.lwt.2016.08.036 ↗
4. Inhibition of Angiotensin Converting Enzyme, Angiotensin II Receptor Blocking, and Blood Pressure Lowering Bioactivity across Plant Families10.1080/10408398.2011.651176 ↗
5. Inhibition of angiotensin converting enzyme (ACE) activity by polyphenols from tea (Camellia sinensis) and links to processing method10.1039/c1fo10023h ↗
6. Effect of dietary supplementation of ginger and turmeric rhizomes on angiotensin-1 converting enzyme (ACE) and arginase activities in L-NAME induced hypertensive rats10.1016/j.jff.2015.06.011 ↗
7. Antihypertensive properties of flavonoid-rich apple peel extract10.1016/j.foodchem.2012.07.023 ↗
8. Characterization of actinidin from Chinese kiwifruit cultivars and its applications in meat tenderization and production of angiotensin I-converting enzyme (ACE) inhibitory peptides
9. Transcriptome-wide identification of Rauvolfia serpentina microRNAs and Prediction of their potential targets10.1016/j.compbiolchem.2015.12.002 ↗
10. Biological application of green silver nanoparticle synthesized from leaf extract of Rauvolfia serpentina Benth10.1016/S2222-1808(16)61085-X ↗
11. Impact of differential levels of sodium alginate, calcium chloride and basal media on germination frequency of genetically true artificial seeds of Rauvolfia serpentina (L.) Benth. ex Kurz
12. The impact of process parameters on carrier free paracetamol nanosuspension prepared using different stabilizers by antisolvent precipitation method10.1016/j.jddst.2017.10.001 ↗
13. Enhanced bioavailability and hypolipidemic activity of Simvastatin formulations by particle size engineering: Physicochemical aspects and in vivo investigations10.1016/j.bej.2013.08.007 ↗
14. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions10.1016/j.ijpharm.2013.07.056 ↗
15. In vitro and in vivoevaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions10.1016/j.colsurfb.2017.09.056 ↗
16. Production of Nanosuspensions as a tool to improve drug bioavailability: Focus on topical delivery10.2174/1381612821666151027152350 ↗
17. Nile red nanosuspensions as investigative model to study the follicular targeting of drug nanocrystals10.1016/j.ijpharm.2017.03.042 ↗
18. Formulation and process optimization of naproxen nanosuspensions stabilized by hydroxyl propyl methylcellulose10.1016/j.carbpol.2015.03.077 ↗
19. Preparation and in vitro–in vivo evaluation of teniposide nanosuspensions10.1016/j.ijpharm.2014.11.020 ↗
20. Selection of conditions for angiotensin-converting enzyme inhibition assay: Influence of sample preparation and buffer
21. PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome10.1016/j.jconrel.2012.05.037 ↗
22. Crystallization of hydrocortisone acetate: Influence of polymers10.1016/S0378-5173(00)00610-4 ↗
23. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: Effects on physicochemical properties10.1016/j.ejpb.2008.06.014 ↗
24. Enhanced bioavailability of cinnarizine nanosuspensions by particle size engineering: Optimization and physicochemical investigations10.1016/j.msec.2016.02.046 ↗
25. Identifying the correlation between drug/stabilizer properties and critical qualiy attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology10.1016/j.ejps.2012.10.004 ↗
26. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity10.1016/j.ijbiomac.2017.11.170 ↗
27. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)10.1016/j.addr.2012.09.028 ↗
28. Simultaneous release of peptides and phenolics with antioxidant, ACE-inhibitory and anti-inflammatory activities from pinto bean (Phaseolus vulgaris L. var. pinto) proteins by subtilisins10.1016/j.jff.2015.07.010 ↗
29. Angiotensin Converting Enzyme (ACE) inhibitory flavonoids from Erthyroxylum laurifolium10.1016/S0944-7113(96)80075-4 ↗